GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $97,000 | -1.0% | 2,229 | +0.5% | 0.01% | +16.7% |
Q4 2021 | $98,000 | +4.3% | 2,219 | -5.3% | 0.01% | -14.3% |
Q2 2021 | $94,000 | -19.0% | 2,344 | -28.2% | 0.01% | -22.2% |
Q1 2021 | $116,000 | -40.5% | 3,264 | -38.3% | 0.01% | -43.8% |
Q4 2020 | $195,000 | -2.0% | 5,294 | 0.0% | 0.02% | -11.1% |
Q3 2020 | $199,000 | -7.4% | 5,294 | +0.5% | 0.02% | -14.3% |
Q2 2020 | $215,000 | -10.8% | 5,269 | -17.2% | 0.02% | -8.7% |
Q1 2020 | $241,000 | -18.3% | 6,366 | +1.6% | 0.02% | +4.5% |
Q4 2019 | $295,000 | +19.0% | 6,266 | +8.0% | 0.02% | +10.0% |
Q3 2019 | $248,000 | -2.4% | 5,801 | -8.6% | 0.02% | -4.8% |
Q2 2019 | $254,000 | -2.7% | 6,348 | +1.6% | 0.02% | -4.5% |
Q1 2019 | $261,000 | +39.6% | 6,246 | +27.7% | 0.02% | +22.2% |
Q4 2018 | $187,000 | -17.3% | 4,891 | -13.1% | 0.02% | -5.3% |
Q3 2018 | $226,000 | +5.6% | 5,629 | +5.6% | 0.02% | 0.0% |
Q2 2018 | $214,000 | -7.0% | 5,329 | -9.5% | 0.02% | -13.6% |
Q1 2018 | $230,000 | -0.9% | 5,888 | -9.9% | 0.02% | 0.0% |
Q4 2017 | $232,000 | -44.0% | 6,538 | -35.9% | 0.02% | -46.3% |
Q3 2017 | $414,000 | -40.3% | 10,192 | -36.6% | 0.04% | -42.3% |
Q2 2017 | $693,000 | -4.4% | 16,071 | -6.5% | 0.07% | -9.0% |
Q1 2017 | $725,000 | +28.3% | 17,184 | +17.3% | 0.08% | +20.0% |
Q4 2016 | $565,000 | -11.4% | 14,653 | -0.9% | 0.06% | -18.8% |
Q3 2016 | $638,000 | +0.5% | 14,785 | +0.9% | 0.08% | -4.8% |
Q2 2016 | $635,000 | +8.9% | 14,660 | +2.1% | 0.08% | +2.4% |
Q1 2016 | $583,000 | +6.4% | 14,360 | +5.7% | 0.08% | +3.8% |
Q4 2015 | $548,000 | +4.4% | 13,585 | -0.4% | 0.08% | -3.7% |
Q3 2015 | $525,000 | -0.4% | 13,644 | +7.8% | 0.08% | +6.5% |
Q2 2015 | $527,000 | -10.7% | 12,653 | -1.0% | 0.08% | -10.5% |
Q1 2015 | $590,000 | -18.4% | 12,783 | -24.5% | 0.09% | -18.1% |
Q4 2014 | $723,000 | -1.9% | 16,933 | +5.6% | 0.10% | -5.4% |
Q3 2014 | $737,000 | -17.2% | 16,038 | -3.7% | 0.11% | -19.0% |
Q2 2014 | $890,000 | +9.2% | 16,648 | +9.1% | 0.14% | +3.0% |
Q1 2014 | $815,000 | +58.9% | 15,258 | +59.0% | 0.13% | +54.7% |
Q4 2013 | $513,000 | +63.9% | 9,598 | +53.9% | 0.09% | +50.9% |
Q3 2013 | $313,000 | +36.7% | 6,235 | +36.2% | 0.06% | +26.7% |
Q2 2013 | $229,000 | – | 4,578 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |